Analysis Life Sciences Thank You What We Expect the FDA to do in July 2023
Agency IQ
JUNE 29, 2023
to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. The guidance, is an overdue requirement of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. not discontinued) and are available for sale.
Let's personalize your content